C44.1222 — Squamous cell carcinoma of skin of right lower eyelid, including canthus
C44.1222 is a billable, specific ICD-10-CM code for squamous cell carcinoma of skin of right lower eyelid, including canthus. It is valid for submission on a claim.
Risk adjustment
C44.1222 does not map to an HCC and does not risk-adjust under CMS-HCC V28. That is normal — most ICD-10 codes do not. It still needs to be coded correctly; it just will not move a RAF score.
Medicare coverage
C44.1222 is named in 81 Medicare coverage policies — 77 listing it as supporting medical necessity, and 4 listing it as NOT covered. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A59380Billing and Coding: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinomanot covered
- A59382Billing and Coding: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinomanot covered
- A59386Billing and Coding: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinomanot covered
- A59429Billing and Coding: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinomanot covered
Code history
C44.1222 has not changed since FY2024 — no addition, revision or deletion across the three most recent ICD-10-CM releases.
Related codes at this level
Codes that share C44.122. If C44.1222 is not quite right, the correct code is usually one of these.
Questions about C44.1222
- Is C44.1222 a billable ICD-10-CM code?
- Yes. C44.1222 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C44.1222 sit in the tabular list?
- Neoplasms (C00-D49), in the block Melanoma and other malignant neoplasms of skin (C43-C44).